Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Exact Sciences Corp EXAS

Healthcare Biotechnology
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test... see more

Recent & Breaking News (NDAQ:EXAS)

Exact Sciences to participate in November investor conferences

PR Newswire November 1, 2023

Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection

PR Newswire October 22, 2023

Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress

PR Newswire October 20, 2023

Exact Sciences schedules third quarter 2023 earnings call

PR Newswire October 9, 2023

Exact Sciences to Present Late-Breaking Data from Pivotal BLUE-C Study on Next-Generation Cologuard at ACG 2023

PR Newswire October 9, 2023

Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience

Business Wire September 12, 2023

Exact Sciences to participate in September investor conference

PR Newswire September 1, 2023

Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials

PR Newswire August 30, 2023

Not a Wall, But an Obstacle Course: New Findings Reveal Why 45-Year-Olds Are Avoiding Colorectal Cancer Screenings

PR Newswire August 21, 2023

Exact Sciences Announces Second-Quarter 2023 Results

PR Newswire August 1, 2023

Exact Sciences schedules second quarter 2023 earnings call

PR Newswire July 10, 2023

Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations

PR Newswire June 21, 2023

Next-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent Specificity, Raising the Bar in Non-invasive Screening

PR Newswire June 20, 2023

EXACT SCIENCES EARNS 2023 GREAT PLACE TO WORK® CERTIFICATION(TM)

PR Newswire June 1, 2023

Exact Sciences to participate in June investor conferences

PR Newswire June 1, 2023

Exact Sciences Presents New Long-Term Patient Outcomes in Multi-Cancer Early Detection and Breast Cancer Recurrence Testing at ASCO® 2023

PR Newswire May 26, 2023

EXACT SCIENCES AWARDS GRANTS TO 18 ORGANIZATIONS FOCUSED ON INCREASING COLORECTAL CANCER SCREENINGS

PR Newswire May 17, 2023

Exact Sciences Announces First Quarter 2023 Results

PR Newswire May 9, 2023

Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week® Annual Meeting

PR Newswire May 9, 2023

Exact Sciences to participate in May investor conference

PR Newswire May 1, 2023